BridgeBio Pharma BBIO Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by BridgeBio Pharma in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.
The official record: BridgeBio Pharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BridgeBio Pharma's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BridgeBio Pharma's change in AP?
- BridgeBio Pharma (BBIO) reported change in AP of -$7.17M in Q1 2026.
- How has BridgeBio Pharma's change in AP changed year-over-year?
- BridgeBio Pharma's change in AP decreased by 140.8% year-over-year, from $17.57M to -$7.17M.
- What does change in AP mean?
- The change in money the company owes to its suppliers.
- How do you interpret change in AP?
- An increase provides a cash benefit, while a decrease indicates the company is paying down its obligations faster.
- How does change in AP compare across companies?
- Commonly used to benchmark how effectively a company manages its vendor payment cycles.